LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024Business Wire • 4 days ago
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the...
Share to Feed
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company) today announced that a majority of the independent members of LENSARs board of directors granted two newly-hired non-executive employees stock...
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company) today announced that a majority of the independent members of LENSARs board of directors granted three newly-hired non-executive employees stock...
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial...
LENSAR, Inc. (LNSR) Q4 2023 Earnings Call Transcript...
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company) today announced that a majority of the independent members of LENSARs board of directors granted seven newly-hired non-executive employees stock...
LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the...
Pulse Biosciences (NASDAQ:PLSE Get Free Report) and LENSAR (NASDAQ:LNSR Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast...
LENSAR, Inc. (NASDAQ:LNSR Get Free Report)s stock price was down 11% during mid-day trading on Tuesday . The stock traded as low as $3.91 and last traded at $3.96. Approximately...
BTIG analyst Ryan Zimmerman maintained a Buy rating on LENSAR (LNSR Research Report) yesterday and set a price target of $8.00. The company's sha...